Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure

Damment, Stephen; Secker, Roger; Shen, Victor; Lorenzo, Victor; Rodriguez, Mariano
June 2011
Nephrology Dialysis Transplantation;Jun2011, Vol. 26 Issue 6, p1803
Academic Journal
Background. Lanthanum carbonate (FOSRENOL®, Shire Pharmaceuticals) is an effective non-calcium, non-resin phosphate binder for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). In this study, we used a rat model of chronic renal failure (CRF) to examine the long-term effects of controlling serum phosphorus with lanthanum carbonate treatment on the biochemical and bone abnormalities associated with CKD–mineral and bone disorder (CKD–MBD).Methods. Rats were fed a normal diet (normal renal function, NRF), or a diet containing 0.75% adenine for 3 weeks to induce CRF. NRF rats continued to receive normal diet plus vehicle or normal diet supplemented with 2% (w/w) lanthanum carbonate for 22 weeks. CRF rats received a diet containing 0.1% adenine, with or without 2% (w/w) lanthanum carbonate. Blood and urine biochemistry were assessed, and bone histomorphometry was performed at study completion.Results. Treatment with 0.75% adenine induced severe CRF, as demonstrated by elevated serum creatinine. Hyperphosphataemia, hypocalcaemia, elevated calcium × phosphorus product and secondary hyperparathyroidism were evident in CRF + vehicle animals. Treatment with lanthanum carbonate reduced hyperphosphataemia and secondary hyperparathyroidism in CRF animals (P < 0.05), and had little effect in NRF animals. Bone histomorphometry revealed a severe form of bone disease with fibrosis in CRF + vehicle animals; lanthanum carbonate treatment reduced the severity of the bone abnormalities observed, particularly woven bone formation and fibrosis.Conclusions. Long-term treatment with lanthanum carbonate reduced the biochemical and bone abnormalities of CKD–MBD in a rat model of CRF.


Related Articles

  • Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Taal, Maarten W.; Brenner, Barry M. // Kidney International;May2000, Vol. 57 Issue 5, p1803 

    Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. In landmark clinical trials, pharmacological inhibition of the renin-angiotensin system (RAS) with angiotensin-converting enzyme inhibitors (ACEIs) attenuated the decline in renal function associated with chronic...

  • Comparative Efficacy of Three Brands of Gum Acacia on Adenine- Induced Chronic Renal Failure in Rats. ALI, B. H.; BEEGAM, S.; AL-LAWATI, I.; WALY, M. I.; ZA'ABI, M. AL; NEMMAR, A. // Physiological Research;2013, Vol. 62 Issue 1, p47 

    Gum acacia (GA) is used in pharmaceutical, cosmetic and food industries as an emulsifier and stabilizer, and in some countries in the traditional treatment of patients with chronic kidney disease (CKD). We have previously found that GA ameliorates adenine -induced chronic renal failure (CRF) in...

  • Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure. Li, Ping; Ma, Lin-lin; Xie, Ru-juan; Xie, Yuan-sheng; Wei, Ri-bao; Yin, Min; Wang, Jian-zhong; Chen, Xiang-mei // Acta Pharmacologica Sinica;May2012, Vol. 33 Issue 5, p644 

    AbstractAim:Sulodexide, a glycosaminoglycan, could reduce albuminuria in diabetic patients. The aim of this study was to determine whether sulodexide could be used to treat chronic kidney failure in rats.Methods:Sixty Wistar rats undergone 5/6 nephrectomy, then were randomly divided into 4...

  • Treatment of experimental renal osteodystrophy with pamidronate. Jokihaara, Jarkko; Pörsti, Ilkka H.; Kööbi, Peeter; Jolma, Pasi M.; Mustonen, Jukka T.; Saha, Heikki H. T.; Sievänen, Harri; Kannus, Pekka; Iwaniec, Urszula T.; Turner, Russell T.; Järvinen, Teppo L. N. // Kidney International;Aug2008, Vol. 74 Issue 3, p319 

    We evaluated the effects of the bisphosphonate pamidronate on bone histomorphometry, structure and strength in male rats with uninephrectomy or with chronic renal disease induced by 5/6 nephrectomy. In rats with chronic renal disease the plasma urea, phosphate and parathyroid hormone levels were...

  • Prevention of vascular calcification: is pyrophosphate therapy a solution? Persy, Veerle P.; McKee, Marc D. // Kidney International;Mar2011, Vol. 79 Issue 5, p490 

    Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the extracellular environment, binds to calcium and mineral surfaces to inhibit crystal growth. O'Neill and colleagues show in uremic rats that systemic administration of pyrophosphate prevents or...

  • CKD ANAEMIA.  // Nephrology Dialysis Transplantation;May2014, Vol. 29 Issue suppl_3, piii140 

    No abstract available.

  • Effect of Atracylodes Rhizome Polysaccharide in Rats with Adenine-Induced Chronic Renal Failure. YANG, C.; LIU, C.; ZHOU, Q.; XIE, Y. C.; QIU, X. M.; FENG, X. // Indian Journal of Pharmaceutical Sciences;Jan/Feb2015, Vol. 77 Issue 1, p103 

    The aim of the study was to elucidate the therapeutic effects of Atracylodes rhizome polysaccharide on adenine-induced chronic renal failure in rats. Fifty male Sprague Dawley rats were selected and randomly divided in to 5 groups (n=10 rats per group): The normal control group, the chronic...

  • Effect of some antioxidants on the prostate of adult and aged albino rats: a histological and immunohistochemical study. Sayed Gabry, Mohamed; Abdel Kader, Dina Helmy; Moustafa, Maiada; Hamed Elenany, Asmaa Abdel // GeroFam;Feb2014, Vol. 4 Issue 2, p17 

    Effect of some antioxidants on the prostate of adult and aged albino rats. Twenty-five adult and twenty-five aged male albino rats were divided into four groups: group I (control group) group II (zinc sulphate treated group), group III (vitamin E) & group IV (vitamin C) zinc administered in...

  • Viscoelastic Parameters for Quantifying Liver Fibrosis: Three-Dimensional Multifrequency MR Elastography Study on Thin Liver Rat Slices. Ronot, Maxime; Lambert, Simon A.; Wagner, Mathilde; Garteiser, Philippe; Doblas, Sabrina; Albuquerque, Miguel; Paradis, Valérie; Vilgrain, Valérie; Sinkus, Ralph; Van Beers, Bernard E. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Objective: To assess in a high-resolution model of thin liver rat slices which viscoelastic parameter at three-dimensional multifrequency MR elastography has the best diagnostic performance for quantifying liver fibrosis. Materials and Methods: The study was approved by the ethics committee for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics